PT1152762E - Utilizacao de desoxipeganina no tratamento da demencia de alzheimer - Google Patents
Utilizacao de desoxipeganina no tratamento da demencia de alzheimerInfo
- Publication number
- PT1152762E PT1152762E PT00907513T PT00907513T PT1152762E PT 1152762 E PT1152762 E PT 1152762E PT 00907513 T PT00907513 T PT 00907513T PT 00907513 T PT00907513 T PT 00907513T PT 1152762 E PT1152762 E PT 1152762E
- Authority
- PT
- Portugal
- Prior art keywords
- dementia
- alzheimer
- treatment
- deoxygeganin
- desoxypeganine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19906975A DE19906975B4 (de) | 1999-02-19 | 1999-02-19 | Arzneiform zur Behandlung von Alzheimer'scher Demenz |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1152762E true PT1152762E (pt) | 2005-08-31 |
Family
ID=7898022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT00907513T PT1152762E (pt) | 1999-02-19 | 2000-02-08 | Utilizacao de desoxipeganina no tratamento da demencia de alzheimer |
Country Status (10)
Country | Link |
---|---|
US (1) | US6436937B1 (pt) |
EP (1) | EP1152762B8 (pt) |
JP (1) | JP2002537256A (pt) |
KR (1) | KR20010102219A (pt) |
AT (1) | ATE294584T1 (pt) |
AU (1) | AU2907700A (pt) |
DE (2) | DE19906975B4 (pt) |
ES (1) | ES2242605T3 (pt) |
PT (1) | PT1152762E (pt) |
WO (1) | WO2000048599A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19906979B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
DE19906978B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit |
AU2001286861A1 (en) * | 2000-08-28 | 2002-03-13 | Sention, Inc. | Use of methylphenidate compounds to enhance memory |
JP2004507503A (ja) * | 2000-08-28 | 2004-03-11 | センション,インコーポレイテッド | 記憶を増強するためのトレオ−メチルフェニデートの使用 |
DE10119863A1 (de) * | 2001-04-24 | 2002-11-07 | Hf Arzneimittelforsch Gmbh | Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen |
DE10163667B4 (de) * | 2001-12-21 | 2006-10-26 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung der klinischen Depression |
WO2004004733A1 (en) * | 2002-07-09 | 2004-01-15 | Actelion Pharmaceuticals Ltd. | 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo[2,1-b]-quinazolinone derivatives |
DE10304141B4 (de) | 2003-02-03 | 2006-03-09 | Hf Arzneimittelforschung Gmbh | Verfahren zur Herstellung von Chinazolin-Alkaloiden |
DE10354893B4 (de) * | 2003-11-24 | 2011-03-10 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen |
CN101433565B (zh) * | 2008-11-26 | 2013-06-05 | 上海中医药大学 | 骆驼蓬属种子总生物碱提取物和它们的制备 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU605614A1 (ru) * | 1971-10-20 | 1978-05-05 | Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср | Антихолинэстеразное средство |
SU878295A1 (ru) * | 1979-07-04 | 1981-11-07 | Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узсср | Способ получени дезоксипеганина гидрохлорида |
US5750542A (en) | 1993-09-28 | 1998-05-12 | Pfizer | Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors |
DE19509663A1 (de) * | 1995-03-17 | 1996-09-19 | Lohmann Therapie Syst Lts | Verfahren zur Isolierung von Galanthamin |
SE9504618D0 (sv) * | 1995-12-22 | 1995-12-22 | Astra Ab | New Compounds |
-
1999
- 1999-02-19 DE DE19906975A patent/DE19906975B4/de not_active Expired - Fee Related
-
2000
- 2000-02-08 WO PCT/EP2000/000972 patent/WO2000048599A1/de not_active Application Discontinuation
- 2000-02-08 ES ES00907513T patent/ES2242605T3/es not_active Expired - Lifetime
- 2000-02-08 AT AT00907513T patent/ATE294584T1/de not_active IP Right Cessation
- 2000-02-08 AU AU29077/00A patent/AU2907700A/en not_active Abandoned
- 2000-02-08 KR KR1020017010459A patent/KR20010102219A/ko not_active Application Discontinuation
- 2000-02-08 US US09/913,638 patent/US6436937B1/en not_active Expired - Fee Related
- 2000-02-08 EP EP00907513A patent/EP1152762B8/de not_active Expired - Lifetime
- 2000-02-08 DE DE50010234T patent/DE50010234D1/de not_active Expired - Fee Related
- 2000-02-08 JP JP2000599391A patent/JP2002537256A/ja active Pending
- 2000-02-08 PT PT00907513T patent/PT1152762E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
JP2002537256A (ja) | 2002-11-05 |
DE50010234D1 (de) | 2005-06-09 |
EP1152762B1 (de) | 2005-05-04 |
WO2000048599A1 (de) | 2000-08-24 |
ATE294584T1 (de) | 2005-05-15 |
AU2907700A (en) | 2000-09-04 |
EP1152762B8 (de) | 2005-06-29 |
KR20010102219A (ko) | 2001-11-15 |
EP1152762A1 (de) | 2001-11-14 |
ES2242605T3 (es) | 2005-11-16 |
DE19906975B4 (de) | 2004-04-15 |
DE19906975A1 (de) | 2000-08-24 |
US6436937B1 (en) | 2002-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20022531D0 (no) | Vaksine for forebyggelse og behandling av Alzheimer og amyloidrelaterte sykdommer | |
EP0735870A4 (en) | USE OF PHOSPHOLIPASE-A2 INHIBITORS FOR TREATING ALZHEIMER'S DISEASE | |
GB0005251D0 (en) | Therapeutic compounds | |
HK1087398A1 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
EP1767197A3 (en) | Treatment of Alzheimer's disease with inhibitors of cell cycle re-entry and progression | |
LU90856I2 (fr) | Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables | |
ATE455106T1 (de) | Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen | |
ATE385794T1 (de) | Benzothiazolderivate zur behandlung von alzheimer und parkinson | |
AU2003284968A8 (en) | Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease | |
AU5716898A (en) | Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease | |
HK1050860A1 (en) | Nordihydroguaiaretic derivatives for use in treatment of tumors | |
UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
AU2002335794A1 (en) | Allylamides useful in the treatment of alzheimer's disease | |
PT1152762E (pt) | Utilizacao de desoxipeganina no tratamento da demencia de alzheimer | |
PT1007040E (pt) | Utilizacao de fanquinona no tratamento da doenca de alzheimer | |
DE69420229D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
MX9707642A (es) | Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos. | |
EE04235B1 (et) | Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks | |
CA2260863A1 (en) | Treatment of psychotic disorders | |
ATE236633T1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen | |
FI953725A0 (fi) | Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksi | |
UA36252A (uk) | Спосіб визначення індивідуальності хворого для вибору адекватної гомеопатичної терапії | |
EP1423144A4 (en) | METHOD AND COMPOUNDS FOR INTERRUPTING THE CD40R / CD40L SIGNAL TRANSMISSION IN THE TREATMENT OF ALZHEIMER DISEASE | |
UA33498A (uk) | Спосіб лікування терапевтично резистентних форм шизофренії | |
GB9910197D0 (en) | Multivalent agents for use in the treatment of mitochondrial diseases |